| 000 | 01836 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517110559.0 | ||
| 264 | 0 | _c20180530 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep30749 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClutton, G | |
| 245 | 0 | 0 |
_aThe differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function. _h[electronic resource] |
| 260 |
_bScientific reports _c08 2016 |
||
| 300 |
_a30749 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xcytology |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aHIV Infections _ximmunology |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPanobinostat |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _xcytology |
| 650 | 0 | 4 |
_aVirus Latency _xdrug effects |
| 650 | 0 | 4 | _aVorinostat |
| 700 | 1 | _aXu, Y | |
| 700 | 1 | _aBaldoni, P L | |
| 700 | 1 | _aMollan, K R | |
| 700 | 1 | _aKirchherr, J | |
| 700 | 1 | _aNewhard, W | |
| 700 | 1 | _aCox, Kara | |
| 700 | 1 | _aKuruc, J D | |
| 700 | 1 | _aKashuba, A | |
| 700 | 1 | _aBarnard, R | |
| 700 | 1 | _aArchin, N | |
| 700 | 1 | _aGay, C L | |
| 700 | 1 | _aHudgens, M G | |
| 700 | 1 | _aMargolis, D M | |
| 700 | 1 | _aGoonetilleke, N | |
| 773 | 0 |
_tScientific reports _gvol. 6 _gp. 30749 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep30749 _zAvailable from publisher's website |
| 999 |
_c26287356 _d26287356 |
||